Research Article
TMUB1 Correlated with Immune Infiltration Is a Prognostic Marker for Colorectal Cancer
Table 1
Characteristics of patients with colorectal cancer based on TCGA.
| | Characters | Level | Overall |
| | | 619 | | T stage (%) | T1 | 20 (3.2%) | | T2 | 105 (17.0%) | | T3 | 422 (68.2%) | | T4 | 70 (11.3%) | | N stage (%) | N0 | 351 (57.0%) | | N1 | 150 (24.4%) | | N2 | 115 (18.7%) | | M stage (%) | M0 | 459 (84.1%) | | M1 | 87 (15.9%) | | Pathologic stage (%) | Stage I | 105 (17.5%) | | Stage II | 227 (37.9%) | | Stage III | 179 (29.9%) | | Stage IV | 88 (14.7%) | | Gender (%) | Female | 289 (46.7%) | | Male | 330 (53.3%) | | CEA level (%) | <=5 | 252 (63.5%) | | >5 | 145 (36.5%) | | History of colon polyps (%) | No | 364 (68.4%) | | Yes | 168 (31.6%) | | Colon polyps present (%) | No | 207 (69.5%) | | Yes | 91 (30.5%) | | Neoplasm type (%) | Colon adenocarcinoma | 454 (73.3%) | | Rectum adenocarcinoma | 165 (26.7%) | | TP53 status (%) | Mut | 312 (59.3%) | | WT | 214 (40.7%) | | KRAS status (%) | Mut | 214 (40.7%) | | WT | 312 (59.3%) | | PIK3CA status (%) | Mut | 133 (25.3%) | | WT | 393 (74.7%) | | Residual tumor (%) | R0 | 450 (91.5%) | | R1 | 6 (1.2%) | | R2 | 36 (7.3%) | | Race (%) | Asian | 12 (3.3%) | | Black or African American | 65 (17.6%) | | White | 292 (79.1%) | | Age (%) | <=65 | 269 (43.5%) | | >65 | 350 (56.5%) | | Weight (%) | <=90 | 231 (71.5%) | | >90 | 92 (28.5%) | | Height (%) | <170 | 146 (48.0%) | | > =170 | 158 (52.0%) | | Age (median [IQR]) | | 68.00 [58.00, 76.00] | | Height (median [IQR]) | | 170.00 [162.00, 176.22] | | Weight (median [IQR]) | | 79.60 [65.00, 92.50] |
|
|
